Stock Split - Spark Newswire

1 minute read

Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate

Today, 2:25 PM

Rockwell Medical Inc (NASDAQ:RMTI) has provided the FDA with the supplemental data requested by the agency in December 2021 for its…

RMTI

1 minute read

Rockwell Medical Announces 1-for-11 Reverse Stock Split, Effective May 13

By Bill Haddad

Today, 2:25 PM

WIXOM, Mich., May 12, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ:RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that its

RMTI

2 minute read

HIVE Blockchain Late Tuesday Proposed 5 To 1 Share Consolidation

By Benzinga Newsdesk

Today, 2:25 PM

HIVE Blockchain Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: HBF) (the "Company" or "HIVE") announces that it intends to complete a consolidation (the "Consolidation") of its common

HIVE

1 minute read

Brookfield Infrastructure Clocks 27% Top-Line Growth In Q1; Plans Stock Split

By Akanksha Bakshi

Today, 2:25 PM

Brookfield Infrastructure Partners L.P (TSX:BIP) (NYSE:BIP) reported a first-quarter FFO per unit of $0.96, an improvement from $0.93 a year…

BIP

1 minute read

Brookfield Infrastructure Partners Exchange Reports 3-For-2 Unit Split, Effective Jun. 10, 2022

By Benzinga Newsdesk

Today, 2:25 PM

Brookfield Infrastructure Partners Exchange L.P. (“BIP Exchange LP”), a subsidiary of Brookfield Infrastructure Partners L.P. (“BIP”), today announced that, in connection with the announcement by

BIP

2 minute read

Field Trip Health To Divide Into Two Separate Public Companies

By Fermin Orgambide

Today, 2:25 PM

Field Trip Health (NASDAQ: FTRP) will divide two of its divisions into public companies of their own.

FTRP

1 minute read

BIOLASE Reports Stock Will Begin Trading On 1-For-25 Reverse Split Basis, Effective Apr. 29, 2022

By Benzinga Newsdesk

Today, 2:25 PM

BIOLASE, Inc. (NASDAQ:BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted the Board of

BIOL

1 minute read

Mydecine Announces 1-for-50 Reverse Stock Split

By Fermin Orgambide

Today, 2:25 PM

The board of directors of Mydecine Innovations Group Inc. (OTCPK:MYCOF) voted in favor of completing a reverse stock split. With this action, the company will consolidate all issued and outstanding shares on a base of 1-for-50. According to Mydecine, the consolidation is expected to reduce the number of common shares from 268,515,954 to 5,370,319.

MYCOF